MDM2 and melanoma: We failed to find obvious changes of DUSP6 expression after activation of p53 by MDM2 inhibitors in melanoma cell lines, despite clear induction of p53 and a previous suggestion of DUSP6 as a p53 direct transcriptional target [18].